StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Regenerative Medical Technology profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Regenerative Medical Technology's profit margin for the twelve months ending Jun 30, 2026 was -101.2%. For fiscal 2025 it was -153.2%, against -135.4% the year before. The highest annual figure on record is -135.4% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-153.2%−17.7
FY2024Dec 31, 2024-135.4%+271.8
FY2023Dec 31, 2023-407.2%−47.3
FY2022Dec 31, 2022-359.9%+2582.6
FY2021Dec 31, 2021-2942.4%+7761.0
FY2020Dec 31, 2020-10703.5%−2368.3
FY2019Dec 31, 2019-8335.2%−4229.6
FY2018Dec 31, 2018-4105.6%−2816.3
FY2017Dec 31, 2017-1289.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-72.2%+74.6
Q1 FY2026Mar 31, 2026-33.2%+22.5
Q4 FY2025Dec 31, 2025-88.6%−46.4
Q3 FY2025Sep 30, 2025-368.8%−278.8
Q2 FY2025Jun 30, 2025-146.8%+115.0
Q1 FY2025Mar 31, 2025-55.7%+184.3
Q4 FY2024Dec 31, 2024-42.2%−0.6
Q3 FY2024Sep 30, 2024-89.9%+815.6
Q2 FY2024Jun 30, 2024-261.8%+300.1
Q1 FY2024Mar 31, 2024-240.0%−27.6
Q4 FY2023Dec 31, 2023-41.6%+133.7
Q3 FY2023Sep 30, 2023-905.5%−539.9
Q2 FY2023Jun 30, 2023-561.8%−60.0
Q1 FY2023Mar 31, 2023-212.4%+348.9
Q4 FY2022Dec 31, 2022-175.3%+446.5
Q3 FY2022Sep 30, 2022-365.6%+5642.2
Q2 FY2022Jun 30, 2022-501.8%+5370.9
Q1 FY2022Mar 31, 2022-561.3%+10069.0
Q4 FY2021Dec 31, 2021-621.7%−213973.9
Q3 FY2021Sep 30, 2021-6007.8%+54323.9
Q2 FY2021Jun 30, 2021-5872.8%+5905.2
Q1 FY2021Mar 31, 2021-10630.4%−3154.5
Q4 FY2020Dec 31, 2020213352.2%+234964.6
Q3 FY2020Sep 30, 2020-60331.7%−32447.7
Q2 FY2020Jun 30, 2020-11778.0%−52696.3
Q1 FY2020Mar 31, 2020-7475.9%+15040.0
Q4 FY2019Dec 31, 2019-21612.4%−10401.1
Q3 FY2019Sep 30, 2019-27884.0%−22509.2
Q2 FY2019Jun 30, 201940918.4%+40534.6
Q1 FY2019Mar 31, 2019-22515.9%−21735.2
Q4 FY2018Dec 31, 2018-11211.3%–
Q3 FY2018Sep 30, 2018-5374.8%–
Q2 FY2018Jun 30, 2018383.8%–
Q1 FY2018Mar 31, 2018-780.7%–

More Regenerative Medical Technology figures

See a number that looks wrong?